ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
122 hedge funds and large institutions have $586M invested in Array Biopharma Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 35
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
122
Holding in Top 10
3
Calls
$4.84M
Puts
$4.32M
Top Buyers
| 1 | +$16.6M | |
| 2 | +$6.15M | |
| 3 | +$4.73M | |
| 4 |
Axa
Paris,
France
|
+$4.04M |
| 5 |
O
OrbiMed
New York
|
+$4M |
Top Sellers
| 1 | -$9.95M | |
| 2 | -$9.6M | |
| 3 | -$7.06M | |
| 4 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$6.65M |
| 5 |
AC
Apex Capital
Orinda,
California
|
-$5.19M |